Harnessing big data to advance treatment and understanding of pulmonary hypertension
Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …
Pulmonary hypertension: a contemporary review
S Johnson, N Sommer, K Cox-Flaherty… - American Journal of …, 2023 - atsjournals.org
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …
associated with lung disease, and chronic thromboembolic PH cast new light on the …
Studying molecular interactions via capillary electrophoresis and microscale thermophoresis: A review
M Asmari, L Michalcová, AE Ibrahim, Z Glatz… - …, 2023 - Wiley Online Library
The process of choosing the most proper technique for studying the molecular interactions is
based on critical factors such as instrumentation complexity, automation, experimental …
based on critical factors such as instrumentation complexity, automation, experimental …
[HTML][HTML] Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension
Y Ye, Q Xu, T Wuren - Frontiers in Immunology, 2023 - frontiersin.org
Hypoxic pulmonary hypertension (HPH) is a complicated vascular disorder characterized by
diverse mechanisms that lead to elevated blood pressure in pulmonary circulation. Recent …
diverse mechanisms that lead to elevated blood pressure in pulmonary circulation. Recent …
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS‐CoV‐2 infection
The pathobiology of in situ pulmonary thrombosis in acute respiratory distress syndrome
(ARDS) due to severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection is …
(ARDS) due to severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection is …
Human umbilical cord mesenchymal stem cell-derived treatment of severe pulmonary arterial hypertension
G Hansmann, P Chouvarine, F Diekmann… - Nature Cardiovascular …, 2022 - nature.com
Here we report application of human umbilical cord mesenchymal stem cell (HUCMSC)-
derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented …
derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented …
Evidence of advanced pulmonary vascular remodeling in obstructive hypertrophic cardiomyopathy with pulmonary hypertension
Background Elevated mean pulmonary artery pressure (mPAP) is common in patients with
hypertrophic cardiomyopathy (HCM) and heart failure symptoms. However, dynamic left …
hypertrophic cardiomyopathy (HCM) and heart failure symptoms. However, dynamic left …
Chronic thromboembolic pulmonary hypertension: the bench
Abstract Purpose of Review Chronic thromboembolic pulmonary hypertension (CTEPH) is
an uncommon complication of acute pulmonary embolism (PE), in which the red, platelet …
an uncommon complication of acute pulmonary embolism (PE), in which the red, platelet …
Plasma NEDD9 is increased following SARS‐CoV‐2 infection and associates with indices of pulmonary vascular dysfunction
Compared to healthy volunteers, participants with post‐acute sequelae of SARS‐CoV‐2
infection (PASC) demonstrated increased plasma levels of the prothrombotic protein …
infection (PASC) demonstrated increased plasma levels of the prothrombotic protein …
Transcriptome analysis reveals differential gene expression between the closing ductus arteriosus and the patent ductus arteriosus in humans
J Saito, T Kojima, S Tanifuji, Y Kato, S Oka… - Journal of …, 2021 - mdpi.com
The ductus arteriosus (DA) immediately starts closing after birth. This dynamic process
involves DA-specific properties, including highly differentiated smooth muscle, sparse elastic …
involves DA-specific properties, including highly differentiated smooth muscle, sparse elastic …